Information Provided By: 
Fly News Breaks for November 6, 2019
EVH
Nov 6, 2019 | 07:31 EDT
Canaccord analyst Richard Close said the Evolent Health Q3 results and Q4 guidance along with positive commentary on 2020 visibility of growth and margin improvement are good enough to support the stock. The analyst said he anticipates an upward move in the stock given its short position, positive pipeline commentary, and guidance raise in adjusted services revenue. Close reiterated his Buy rating and $19 price target on Evolent Health shares.
News For EVH From the Last 2 Days
There are no results for your query EVH
